These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 1655257

  • 1. Phenotype and function of natural killer cells in patients with bronchogenic carcinoma.
    LeFever AV, Funahashi A.
    Cancer Res; 1991 Oct 15; 51(20):5596-601. PubMed ID: 1655257
    [Abstract] [Full Text] [Related]

  • 2. Cord blood CD16+56- cells with low lytic activity are possible precursors of mature natural killer cells.
    Gaddy J, Broxmeyer HE.
    Cell Immunol; 1997 Sep 15; 180(2):132-42. PubMed ID: 9341743
    [Abstract] [Full Text] [Related]

  • 3. Evidence for local and systemic activation of immune cells by peritumoral injections of interleukin 2 in patients with advanced squamous cell carcinoma of the head and neck.
    Whiteside TL, Letessier E, Hirabayashi H, Vitolo D, Bryant J, Barnes L, Snyderman C, Johnson JT, Myers E, Herberman RB.
    Cancer Res; 1993 Dec 01; 53(23):5654-62. PubMed ID: 8242620
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Characterization of the cytolytic activity of CD4+ and CD8+ tumor-infiltrating lymphocytes in human renal cell carcinoma.
    Finke JH, Rayman P, Alexander J, Edinger M, Tubbs RR, Connelly R, Pontes E, Bukowski R.
    Cancer Res; 1990 Apr 15; 50(8):2363-70. PubMed ID: 2107973
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Decreased natural killer cytotoxic activity in chronic alcoholism is associated with alcohol liver disease but not active ethanol consumption.
    Laso FJ, Madruga JI, Girón JA, López A, Ciudad J, San Miguel JF, Alvarez-Mon M, Orfao A.
    Hepatology; 1997 May 15; 25(5):1096-100. PubMed ID: 9141423
    [Abstract] [Full Text] [Related]

  • 8. Beneficial effects of interleukin-2 on natural killer activity in lung cancer patients.
    Ito M, Suzuki H, Yamashita N, Sugiyama E, Maruyama M, Sato M, Iwata M, Yano S.
    Anticancer Res; 1984 May 15; 4(6):375-8. PubMed ID: 6097158
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Phenotypic and cytolytic activity of Macaca nemestrina natural killer cells isolated from blood and expanded in vitro.
    Shields LE, Sieverkropp AJ, Potter J, Andrews RG.
    Am J Primatol; 2006 Aug 15; 68(8):753-64. PubMed ID: 16847969
    [Abstract] [Full Text] [Related]

  • 11. The correlation between the percent of CD3- CD56+ cells and NK precursor function.
    Gharehbaghian A, Donaldson C, Newman J, Bannister G, Bradley BA.
    Iran J Allergy Asthma Immunol; 2006 Dec 15; 5(4):167-75. PubMed ID: 17237569
    [Abstract] [Full Text] [Related]

  • 12. Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4.
    Keever CA, Pekle K, Gazzola MV, Collins NH, Bourhis JH, Gillio A.
    J Immunol; 1989 Nov 15; 143(10):3241-9. PubMed ID: 2809200
    [Abstract] [Full Text] [Related]

  • 13. The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes.
    Lanier LL, Le AM, Civin CI, Loken MR, Phillips JH.
    J Immunol; 1986 Jun 15; 136(12):4480-6. PubMed ID: 3086432
    [Abstract] [Full Text] [Related]

  • 14. Increased number of CD16(+)CD56(dim) NK cells in peripheral blood mononuclear cells after allogeneic cord blood transplantation.
    Tanaka J, Sugita J, Asanuma S, Arita K, Shono Y, Kikutchi M, Shiratori S, Wakasa K, Yasumoto A, Shigematu A, Kondo T, Kobayashi T, Asaka M, Imamura M.
    Hum Immunol; 2009 Sep 15; 70(9):701-5. PubMed ID: 19524005
    [Abstract] [Full Text] [Related]

  • 15. A pilot study of intralymphatic interleukin-2. I. Cytotoxic and surface marker changes of peripheral blood lymphocytes.
    Shau H, Isacescu V, Ibayashi Y, Tokuda Y, Golub SH, Fahey JL, Sarna GP.
    J Biol Response Mod; 1990 Feb 15; 9(1):71-80. PubMed ID: 2319261
    [Abstract] [Full Text] [Related]

  • 16. Natural killer and activated killer activities in chronic liver disease and hepatocellular carcinoma: evidence for a decreased lymphokine-induced activity of effector cells.
    Hirofuji H, Kakumu S, Fuji A, Ohtani Y, Murase K, Tahara H.
    Clin Exp Immunol; 1987 May 15; 68(2):348-56. PubMed ID: 2820634
    [Abstract] [Full Text] [Related]

  • 17. Distinct phenotypic and functional characteristics of human natural killer cells obtained by rapid interleukin 2-induced adherence to plastic.
    Vujanovic NL, Rabinowich H, Lee YJ, Jost L, Herberman RB, Whiteside TL.
    Cell Immunol; 1993 Oct 01; 151(1):133-57. PubMed ID: 8402925
    [Abstract] [Full Text] [Related]

  • 18. Natural killer cell immunodeficiency in HIV disease is manifest by profoundly decreased numbers of CD16+CD56+ cells and expansion of a population of CD16dimCD56- cells with low lytic activity.
    Hu PF, Hultin LE, Hultin P, Hausner MA, Hirji K, Jewett A, Bonavida B, Detels R, Giorgi JV.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Nov 01; 10(3):331-40. PubMed ID: 7552495
    [Abstract] [Full Text] [Related]

  • 19. [Antitumor activity of human tumor infiltrating lymphocytes (TIL) and its comparison with peripheral blood lymphocytes (PBL)].
    Xu ZY.
    Zhonghua Zhong Liu Za Zhi; 1990 Sep 01; 12(5):345-7. PubMed ID: 2177396
    [Abstract] [Full Text] [Related]

  • 20. Depression of natural killer cytotoxic activity in lymphocytes infiltrating human pulmonary tumors.
    Moy PM, Holmes EC, Golub SH.
    Cancer Res; 1985 Jan 01; 45(1):57-60. PubMed ID: 3855286
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.